Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Evaluation of Alpha-Type-1 DC-Based and cDC-Based Intralymphatic Vaccines in Patients With Metastatic Melanoma

NCT00390338 is registered in ClinicalTrials.gov with Pawel Kalinski as lead sponsor.

NCT NCT00390338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00390338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Evaluation of Alpha-Type-1 DC-Based and cDC-Based Intralymphatic Vaccines in Patients With Metastatic Melanoma
Lead sponsor
Pawel Kalinski
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2006
Completion date
January 31, 2015
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)